Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in decreased expression of MED13 mRNA | decreases expression | 20406850
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MED13 mRNA | decreases expression | 19150397
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of MED13 mRNA | increases expression | 16324150
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of MED13 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MED13 mRNA | affects cotreatment|increases expression | 17942748
|
C051890 |
irinotecan |
irinotecan analog results in decreased expression of MED13 mRNA | decreases expression | 18927307
|
D012402 |
Rotenone |
Rotenone results in decreased expression of MED13 mRNA | decreases expression | 19013527
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MED13 mRNA | affects cotreatment|increases expression | 17942748
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of MED13 mRNA | increases expression | 16324150
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.18 | 11752688 15322242 14514962 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.32 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.86 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.71 | 16835633 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.81 | 15955085 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.17 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.77 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.67 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.67 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.31 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.40 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.68 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.76 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
9.76 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.17 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.91 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
1.88 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.88 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.88 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.93 | 16813970 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.99 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.54 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.10 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
3.10 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
4.97 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.97 | 16096774 16051514 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.49 | 16120746 18670907 18850075 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.22 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.18 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.18 | 20889678 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.93 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.38 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
3.05 | 16919318 11677210 17681005 17110522 16105132 17333356 15861022 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.54 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
6.05 | 12621046 16354765 15668235 8697196 15340226 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
6.05 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
4.01 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
2.62 | 17287894 17725105 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
2.36 | 18259882 15273666 17159606 18509181 16303861 16391804 17454858 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.50 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.50 | 9664655 10589399 14991402 17551590 9125849 16925845 8800419 9142499 9224671 9211117 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.32 | 18551238 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
3.89 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.89 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.93 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.61 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
13.23 | 18230668 15322242 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
13.23 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
10.05 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
10.05 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.25 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.25 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.12 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
9.43 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
9.43 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
3.05 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.76 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.66 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
9.66 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.15 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.97 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.34 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.54 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.91 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.91 | 9664655 14991402 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.58 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.20 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.42 | 15340226 16959395 8697196 16354765 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.40 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.88 | 16778211 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.98 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.12 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.72 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.64 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.96 | 12878042 12200463 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.07 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.76 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.76 | 15992940 17551590 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.18 | 16705839 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.87 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.94 | 16932348 19285840 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.11 | 16294345 17596541 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.30 | 15748426 17712046 17368321 17294898 17301526 17361223 17217047 16788101 16331271 19075265 19029980 17339181 16766008 16891316 12679006 19642359 17506722 16823087 16935935 17649720 19225113 17107899 16140955 19035177 9834237 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.47 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.36 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.36 | 16248980 18397230 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
4.63 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.63 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.20 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.20 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 19555203 11884234 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.86 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.97 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.73 | 16940565 |
MESH:D052016 |
Mucositis |
|
irinotecan |
5.35 | 17159606 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.20 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.21 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.20 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
3.25 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.51 | 16594593 16946489 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
4.06 | 18619942 17356569 15790535 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.47 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
10.47 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.20 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.59 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
5.07 | 8761367 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.66 | 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.40 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.10 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.53 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.95 | 11578682 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
3.05 | 11445065 18191903 16412576 18619942 19114014 16140633 11535288 19232380 15451049 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
4.30 | 15574749 15927086 18197244 15795934 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.62 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.84 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.53 | 11896295 11118676 11399792 11222880 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
5.12 | 15572423 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
3.50 | 12479363 16289102 18247401 15754350 16644109 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.86 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.65 | 15861022 16919318 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.13 | 16723453 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.12 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.36 | 16283617 16116481 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.69 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.89 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
5.89 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.32 | 16709447 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
2.69 | 15723263 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.69 | 17261132 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.88 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.37 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.28 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.21 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
4.02 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.36 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.37 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.66 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.90 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.58 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.99 | 16752155 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.97 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.78 | 14671159 15869587 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.34 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.62 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.18 | 16287080 |